Literature DB >> 11278808

Prostate apoptosis response-4 enhances secretion of amyloid beta peptide 1-42 in human neuroblastoma IMR-32 cells by a caspase-dependent pathway.

Q Guo1, J Xie, X Chang, H Du.   

Abstract

Prostate apoptosis response-4 (Par-4) is a leucine zipper protein that promotes neuronal cell death in Alzheimer's disease (AD). Neuronal degeneration in AD may result from extracellular accumulation of amyloid beta peptide (Abeta) 1-42. To examine the effect of Par-4 on Abeta secretion and to reconcile amyloid/apoptosis hypotheses of AD, we generated IMR-32 cell lines that overexpress Par-4 and/or its leucine zipper domain. Overexpression of Par-4 did not significantly affect levels of the endogenously expressed beta amyloid precursor protein but drastically increased the Abeta(1-42)/Abeta(total) ratio in the conditioned media about 6-8 h after trophic factor withdrawal. Time course analysis of caspase activation reveals that Par-4 overexpression exacerbated caspase activation, which is detectable within 2 h after trophic factor withdrawal. Furthermore, inhibition of caspase activity by the broad spectrum caspase inhibitor BD-fmk significantly attenuated the Par-4-induced increase in Abeta 1-42 production. In addition, the effects of Par-4 on secretion of Abeta 1-42 were consistently blocked by co-expression of the leucine zipper domain, indicating that the effect of Par-4 on Abeta secretion may require its interaction with other protein(s). These results suggest that Par-4 increases secretion of Abeta 1-42 largely through a caspase-dependent pathway after apoptotic cascades are initiated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278808     DOI: 10.1074/jbc.M010996200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Prostate apoptosis response 4 (Par-4), a novel substrate of caspase-3 during apoptosis activation.

Authors:  Parvesh Chaudhry; Mohan Singh; Sophie Parent; Eric Asselin
Journal:  Mol Cell Biol       Date:  2011-12-19       Impact factor: 4.272

Review 2.  The antiapoptotic activity of melatonin in neurodegenerative diseases.

Authors:  Xin Wang
Journal:  CNS Neurosci Ther       Date:  2009-10-10       Impact factor: 5.243

Review 3.  Apoptosis and tumor resistance conferred by Par-4.

Authors:  Yanming Zhao; Vivek M Rangnekar
Journal:  Cancer Biol Ther       Date:  2008-12-08       Impact factor: 4.742

4.  Cross-linking of cell surface amyloid precursor protein leads to increased β-amyloid peptide production in hippocampal neurons: implications for Alzheimer's disease.

Authors:  Roger Lefort; Julio Pozueta; Michael Shelanski
Journal:  J Neurosci       Date:  2012-08-01       Impact factor: 6.167

5.  siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells.

Authors:  Ramesh J L Kandimalla; Willayat Yousuf Wani; B K Binukumar; Kiran Dip Gill
Journal:  J Biomed Sci       Date:  2012-01-03       Impact factor: 8.410

Review 6.  Mechanism involved in insulin resistance via accumulation of β-amyloid and neurofibrillary tangles: link between type 2 diabetes and Alzheimer's disease.

Authors:  Sima Kianpour Rad; Aditya Arya; Hamed Karimian; Priya Madhavan; Farzana Rizwan; Shajan Koshy; Girish Prabhu
Journal:  Drug Des Devel Ther       Date:  2018-11-22       Impact factor: 4.162

7.  Activation of p38MAPK contributes to expanded polyglutamine-induced cytotoxicity.

Authors:  Maria Tsirigotis; R Mitchell Baldwin; Matthew Y Tang; Ian A J Lorimer; Douglas A Gray
Journal:  PLoS One       Date:  2008-05-07       Impact factor: 3.240

8.  Molecular mechanisms of cognitive dysfunction following traumatic brain injury.

Authors:  Kendall R Walker; Giuseppina Tesco
Journal:  Front Aging Neurosci       Date:  2013-07-09       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.